Condition: Non-Small Cell Lung Cancer · Sponsor: Scientific Institute San Raffaele
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
This description comes directly from the study's public registry record.
Pierluigi Novellis, Medical Doctor · 0226437202 · novellis.pierluigi@hsr.it
Always discuss trial participation with your own doctor first.
| Baptist Health South Florida | Miami, Florida, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| West Virginia University | Morgantown, West Virginia, United States | Recruiting |
| Istituto Clinico Humanitas | Rozzano, Milan, Italy | Recruiting |
| Scientific Institute Ospedale San Raffaele | Milan, Italy | Recruiting |
| Regina Elena National Cancer Institute | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06626243